Cited 4 time in
Inhibitory Actions of HERG Currents by the Immunosuppressant Drug Cyclosporin A
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, Seung Ho | - |
| dc.contributor.author | Hahn, Sang June | - |
| dc.contributor.author | Min, Gyesik | - |
| dc.contributor.author | Kim, Jimok | - |
| dc.contributor.author | Jo, Su-Hyun | - |
| dc.contributor.author | Choe, Han | - |
| dc.contributor.author | Choi, Bok Hee | - |
| dc.date.accessioned | 2022-12-27T02:52:53Z | - |
| dc.date.available | 2022-12-27T02:52:53Z | - |
| dc.date.issued | 2011-10 | - |
| dc.identifier.issn | 1226-4512 | - |
| dc.identifier.issn | 2093-3827 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/23521 | - |
| dc.description.abstract | The effect of cyclosporin A (CsA), an immunosuppressant, on human ether-a-go-go-related gene (HERG) channel as it is expressed in human embryonic kidney cells was studied using a whole-cell, patch-clamp technique. CsA inhibited the HERG channel in a concentration-dependent manner, with an IC(50) value and a Hill coefficient of 3.17 mu M and 0.89, respectively. Pretreatment with cypermethrine, a calcineurin inhibitor, had no effect on the CsA-induced inhibition of the HERG channel. The CsA-induced inhibition of HERG channels was voltage-dependent, with a steep increase over the voltage range of the channel opening. However, the inhibition exhibited voltage independence over the voltage range of fully activated channels. CsA blocked the HERG channels predominantly in the open and inactivated states rather than in the closed state. Results of the present study suggest that CsA acts directly on the HERG channel as an open-channel blocker, and it acts independently of its effect on calcineurin activity. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY | - |
| dc.title | Inhibitory Actions of HERG Currents by the Immunosuppressant Drug Cyclosporin A | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.4196/kjpp.2011.15.5.291 | - |
| dc.identifier.scopusid | 2-s2.0-81455128955 | - |
| dc.identifier.wosid | 000296954900007 | - |
| dc.identifier.bibliographicCitation | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, v.15, no.5, pp 291 - 297 | - |
| dc.citation.title | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY | - |
| dc.citation.volume | 15 | - |
| dc.citation.number | 5 | - |
| dc.citation.startPage | 291 | - |
| dc.citation.endPage | 297 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalResearchArea | Physiology | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Physiology | - |
| dc.subject.keywordPlus | POTASSIUM CHANNELS | - |
| dc.subject.keywordPlus | XENOPUS OOCYTES | - |
| dc.subject.keywordPlus | HEK-293 CELLS | - |
| dc.subject.keywordPlus | K+ CHANNELS | - |
| dc.subject.keywordPlus | IN-VITRO | - |
| dc.subject.keywordPlus | LYMPHOCYTES | - |
| dc.subject.keywordPlus | RECTIFIER | - |
| dc.subject.keywordPlus | BLOCKADE | - |
| dc.subject.keywordPlus | KINASE | - |
| dc.subject.keywordAuthor | Cyclosporin A | - |
| dc.subject.keywordAuthor | Immunosuppressant | - |
| dc.subject.keywordAuthor | HERG | - |
| dc.subject.keywordAuthor | Long QT syndrome | - |
| dc.subject.keywordAuthor | Open channel block | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
